Doppl is a leader in engineering industry-standard organoids for disease modeling and personalized medicine. We are dedicated to providing accurate, high-quality, and scalable in vitro models, leveraging our unparalleled organoid expertise and a network of experts in biopharma and clinical settings. With these models, we help our partners mitigate risks throughout the drug discovery and development process.